Of all the serological tests, IgA anti-TG2 Ab is the most widely used test both for the diagnosis and initial screening for CeD because of its very high sensitivity and specificity, ease of use, and its quantitative capability. Here, CD79A is linked to cranioectodermal dysplasia.